Press Releases

All Releases
May 24, 2011
AngioDynamics Reports Oncology/Surgery Division Developments
U.S. distribution contract for LC Beads ™ to expire on December 31, 2011 FDA approves IDE for NanoKnife ® System study in prostate cancer Company expects to submit IDE for NanoKnife System study in pancreatic cancer by mid-June Oncology/Surgery division to enhance focus on NanoKnife, and
Apr 20, 2011
AngioDynamics to Present at Upcoming Investor Conferences in May 2011
ALBANY, N.Y. --(BUSINESS WIRE)-- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that executive management will present at the following investor conferences in
Displaying 281 - 300 of 701